Kestra Medical Technologies, Ltd. Common Stock
$24.08
-$1.10 (-4.37%)
$23.86Day Range$25.33
Key Statistics
Market Cap
$1.50B
Shares Outstanding
59.6M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Mar 6, 2025
Round Lot
100
Locale
US
Trading Data
Day Open
$25.20
Day High
$25.33
Day Low
$23.86
Volume
825.0K
VWAP
$24.51
Prev Close
$25.18
Transactions
--
Acc. Volume
--
About Kestra Medical Technologies, Ltd. Common Stock
Kestra Medical Technologies Ltd is a commercial-stage wearable medical device and digital healthcare company focused on connected monitoring, therapeutic intervention, and data-driven clinical insights for cardiovascular disease. It has developed and is commercializing the Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery. The platform is anchored by the ASSURE Wearable Cardioverter Defibrillator (WCD), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected. The platform also includes digital patient engagement and clinical workflow solutions.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 3841443 employees3933 LAKE WASHINGTON BLVD NE, KIRKLAND, WA, 98033(425) 279-8002IPO Mar 6, 2025US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001877184
- Ticker Root
- KMTS
- SIC Code
- 3841
About Kestra Medical Technologies, Ltd. Common Stock (KMTS) Stock
Kestra Medical Technologies, Ltd. Common Stock (KMTS) closed the 2026-09-16 session at $24.08, down 4.37% versus the previous close (-1.10). The stock opened at $25.20 and traded between $23.86 and $25.33 during that session. Session trading volume was 825K shares. The volume-weighted average price (VWAP) is $24.51.
Kestra Medical Technologies Ltd is a commercial-stage wearable medical device and digital healthcare company focused on connected monitoring, therapeutic intervention, and data-driven clinical insights for cardiovascular disease. It has developed and is commercializing the Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery. The platform is anchored by the ASSURE Wearable Cardioverter Defibrillator (WCD), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected. The platform also includes digital patient engagement and clinical workflow solutions.
Kestra Medical Technologies, Ltd. Common Stock has a market capitalization of $1.50 billion. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. KMTS is listed on the XNAS exchange. The company employs approximately 443 people. Kestra Medical Technologies, Ltd. Common Stock is headquartered in KIRKLAND, WA. The recorded listing date is 2025-03-06.
On this page you can find market KMTS stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.